| Target Price | ¥4,896.00 |
| Price | ¥4,005.00 |
| Potential |
22.25%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Kissei Pharmaceutical Co 2027 .
The average Kissei Pharmaceutical Co target price is ¥4,896.00.
This is
22.25%
register free of charge
¥5,775.00
44.19%
register free of charge
¥3,797.60
5.18%
register free of charge
|
|
| A rating was issued by 11 analysts: 6 Analysts recommend Kissei Pharmaceutical Co to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kissei Pharmaceutical Co stock has an average upside potential 2027 of
22.25%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 97.41 | 93.23 |
| 10.28% | 4.29% | |
| EBITDA Margin | -0.10% | 8.96% |
| 100.98% | 9,191.23% | |
| Net Margin | 14.15% | 11.73% |
| 4.47% | 17.08% |
8 Analysts have issued a sales forecast Kissei Pharmaceutical Co 2027 . The average Kissei Pharmaceutical Co sales estimate is
This results in the following potential growth metrics:
8 Kissei Pharmaceutical Co Analysts have issued a net profit forecast 2027. The average Kissei Pharmaceutical Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 331.53 | 263.81 |
| 20.91% | 20.43% | |
| P/E | 15.24 | |
| EV/Sales | 1.20 |
8 Analysts have issued a Kissei Pharmaceutical Co forecast for earnings per share. The average Kissei Pharmaceutical Co EPS is
This results in the following potential growth metrics and future valuations:
Kissei Pharmaceutical Co...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


